Drug-induced subacute cutaneous lupus erythematosus

Lupus

Volumn 19, Issue 9, 2010, Pages 1107-1111

  Callen, J P ^a  

^a University of Louisville School of Medicine   (United States)

Author keywords

drug reaction; photosensitivity; subacute cutaneous lupus erythematosus

Indexed keywords

ADALIMUMAB; ALPHA INTERFERON; BETA INTERFERON; CALCIUM CHANNEL BLOCKING AGENT; CAPTOPRIL; CILAZAPRIL; CINNARIZINE; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DOCETAXEL; EFALIZUMAB; ENALAPRIL; ETANERCEPT; GRISEOFULVIN; HYDRALAZINE; HYDROCHLOROTHIAZIDE; INFLIXIMAB; ISONIAZID; LEFLUNOMIDE; LISINOPRIL; MINOCYCLINE; PACLITAXEL; PHENYTOIN; PRAVASTATIN; PROCAINAMIDE; SIMVASTATIN; TERBINAFINE; THIETHYLPERAZINE; TICLOPIDINE; TUMOR NECROSIS FACTOR INHIBITOR; UNINDEXED DRUG;

CLINICAL FEATURE; HIGH RISK PATIENT; HUMAN; PRIORITY JOURNAL; REVIEW; SKIN LUPUS ERYTHEMATOSUS; SKIN MANIFESTATION; SYMPTOM;

HUMANS; HYDROCHLOROTHIAZIDE; LUPUS ERYTHEMATOSUS, CUTANEOUS; PHARMACEUTICAL PREPARATIONS; PHOTOSENSITIVITY DISORDERS; SKIN;

EID: 77955529367     PISSN: 09612033     EISSN: None     Source Type: Journal    
DOI: 10.1177/0961203310370349     Document Type: Review

References (80)

1. Sontheimer RD, Thomas JR, Gilliam JN Subacute cutaneous lupus erythematosus: a cutaneous marker for a distinct lupus erythematosus subset. Arch Dermatol 1979 ; 115: 1409-1415.
2. Sontheimer RD, Maddison PJ, Reichlin M., Jordon RE, Stastny P., Gilliam JN Serologic and HLA associations in subacute cutaneous lupus erythematosus, a clinical subset of lupus erythematosus. Ann Intern Med 1982 ; 97: 664.
3. Black DR, Hornung CA, Schneider PD, Callen JP Frequency and severity of systemic disease in patients with subacute cutaneous lupus erythematosus. Arch Dermatol 2002 ; 138: 1175-1178.
4. Reed BR, Huff JC, Jones SK, Orton PW, Lee LA, Norris DA Subacute cutaneous lupus erythematosus associated with hydrochlorothiazide therapy. Ann Intern Med 1985 ; 103: 49-51.
5. David-Bajar KM Subacute cutaneous lupus erythematosus. J Invest Dermatol 1993 ; 100: 2S - 8S.
6. Callen JP, Hughes AP, Kulp-Shorten C. Subacute cutaneous lupus erythematosus induced or exacerbated by terbinafine: a report of 5 cases. Arch Dermatol 2001 ; 137: 1196-1198.
7. Sontheimer RD, Henderson CL, Grau RH Drug-induced subacute cutaneous lupus erythematosus: a paradigm for bedside-to-bench patient-oriented translational clinical investigation. Arch Dermatol Res 2008 ; 301: 65-70.
8. Chlebus E., Wolska H., Blaszczyk M., Jablonska S. Subacute cutaneous lupus erythematosus versus systemic lupus erythematosus: diagnostic criteria and therapeutic implications. J Am Acad Dermatol 1999 ; 40: 405-412.
9. Brown C., Deng J. Thiazide diuretics induce cutaneous lupus-like adverse reaction. J Toxicol Clin Toxicol 1995 ; 33: 729-733.
10. Parodi A., Romagnoli M., Rebora A. Subacute cutaneous lupus erythematosus-like eruption caused by hydrochlorothiazide. Photodermatol 1989 ; 6: 100-102.
11. Wollenberg A., Meurer M. Thiazide diuretic-induced subacute cutaneous lupus erythematosus. Hautarzt 1991 ; 42: 709-712.
12. Srivastava M., Rencic A., Diglio G., et al. Drug-induced, Ro/SSA-positive cutaneous lupus erythematosus. Arch Dermatol 2003 ; 139: 45-49.
13. Darken M., McBurney E. Subacute cutaneous lupus erythematosus-like drug eruption due to combination diuretic hydrochlorothiazide and triamterene. J Am Acad Dermatol 1988 ; 18: 38-42.
14. Leroy D., Dompmartin A., Le Jean S., Guillemain J., Mandard J., Deschamps P. Dermatitis caused by aldactone of a lupic annular erythema type. Ann Dermatol Venereol 1987 ; 114: 1237-1240 (French).
15. Crowson A., Magro C. Subacute cutaneous lupus erythematosus arising in the setting of a calcium channel blocker therapy. Hum Pathol 1997 ; 28: 67-73.
16. Crowson A., Magro C. Diltiazem and subacute cutaneous lupus erythematosus-like lesions. N Engl J Med 1995 ; 333: 1429.
17. Gubinelli E., Cocuroccia B., Girolomoni G. Subacute cutaneous lupus erythematosus induced by nifedipine. J Cutan Med Surg 2003 ; 7: 243.
18. Marzano A., Borghi A., Mercogliano M., Facchetti M., Caputo R. Nitrndipine-induced subacute cutaneous lupus erythematosus. Eur J Dermatol 2003 ; 13: 213-216. (Pubitemid 36428374)
19. Patri P., Nigro A., Rebora A. Lupus erythematosus-like eruption from captopril. Acta Derm Venereol 1985 ; 65: 447-448.
20. Fernandez-Diaz M., Herranz P., Suarez-Marrero M., Borbujo J., Manzano R., Casado M. Subacute cutaneous lupus erythematosus associated with cilazapril. Lancet 1995 ; 345: 398.
21. Murphy M., Barnes L. Terbinafine-induced lupus erythematosus. Br J Dermatol 1998 ; 138: 708-709.
22. Holmes S., Kemmett D. Exacerbation of systemic lupus erythematosus induced by terbinafine. Br J Dermatol 1998 ; 139: 1111-1137.
23. Brooke R., Coulson I., al-Dawoud A. Terbinafine-induced subacute cutaneous lupus erythematosus. Br J Dermatol 1998 ; 139: 1132-1133.
24. Matthes T., Hagedorn M. Terbinafin-induzierter subakut-kutaner lupus erythematodes. Hautarzt 2004 ; 55: 653-657.
25. Hill V., Chow J., Cowley N., Marsden R. Subacute lupus erythematosus-like eruption due to terbinafine: report of three cases. Br J Dermatol 2003 ; 148: 1056.
26. Bonsmann G., Schiller M., Luger T., Stander S. Terbinafine-induced subacute cutaneous lupus erythematosus. J Am Acad Dermatol 2001 ; 44: 925-931.
27. McKay DA, Schofield OMV, Benton EC Terbinafine-induced subacute cutaneous lupus erythematosus. Acta Derm Venereol 2004 ; 84: 472-474.
28. McKellar G., Porter D., Burden D. Terbinafine as a cause of cutaneous lupus erythematosus. Rheumatology 2004 ; 43: 249.
29. Terreb Z., El Ouzzani T., Zouhair K., El Kabli H., Lakhdar H. Syndrome de Stevens-Johnson et aggravation dn lupus systemique induits par la terbinafine. Ann Dermatol Venereol 2006 ; 133: 463-466.
30. Fahri D., Viguier M., Cosnes A., et al. Terbinafine-induced subacute cutaneous lupus erythematosus. Dermatology 2006 ; 212: 59-65.
31. Cetkovska P., Pizinger K. Coexisting subacute and systemic lupus treatment with mycophenolate mofetil. Int J Dermatol 2006 ; 45: 320-322.
32. Lorentz K., Booken N., Goerdt D., Goebeler M. Subacute cutaneous lupus erythematosus induced by terbinafine: case report and review of literature. J Dtsch Dermatol Ges 2008 ; 6: 823-828.
33. Bleumink G., ter Borg E., Ramselaar C., Ch Stricker B. Etanercept-induced subacute cutaneous lupus erythematosus. Rheumatology 2001 ; 40: 1317-1319.
34. Brion P., Mittal-Henkle A., Kalunian K. Autoimmune skin rashes associated with etanercept for rheumatoid arthritis. Ann Intern Med 1999 ; 131: 634.
35. Carlson E., Rothfield N. Etanercept-induced lupus-like syndrome in a patient with rheumatoid arthritis. Arthritis Rheum 2003 ; 48: 1165-1166. (author reply 1166 ).
36. De Bandt M., Descamps V., Meyer O. Two cases of etanercept-induced lupus-like syndrome in ra patients. Arthritis Rheum 2001 ; 44: S372.
37. Klapman J., Ene-Stroescu D., Becker M., Hanauer S. A lupus-like syndrome associated with infliximab therapy. Inflamm Bowel Dis 2003 ; 9: 176-178.
38. Stratigos AJ, Antoniou C., Stamathioudaki S., Avgerinou G., Tsega A., Katsambas AD Discoid lupus erythematosus-like eruption induced by infliximab. Clin Exp Dermatol 2004 ; 20: 150-153.
39. Schneider SW, Staender S., Schüter B., Luger TA, Bonsmann G. Infliximab-induced lupus erythematosus tumidus in a patient with rheumatoid arthritis. Arch Dermatol 2006 ; 142: 115-156.
40. Sheth N., Greenblatt D., Patel S., Acland K. Adalimumab-induced cutaneous lupus erythematosus. Clin Exp Dermatol 2007 ; 32: 593-594.
41. Spillane AP, Xia Y., Sniezek PJ J Am Acad Dermatol 2007 ; 56: s114 - s115.
42. Martin JM, Ricart JM, Alcacer J., Rausell N., Arana G. Adalimumabinduced lupus erythematosus. Lupus 2008 ; 17: 676-678.
43. Nousari H., Kimyai-Asadi A., Tausk F. Subacute cutaneous lupus erythematosus associated with interferon beta-1a. Lancet 1998 ; 352: 1825-1826.
44. Arrue I., Saiz A., Ortiz-Romero PL, Rodriguez-Peralto JL Lupus-like reaction to interferon at the injection site: report of five cases. J Cutan Pathol 2007 ; 34 (Suppl 1). 18-21.
45. Bentley DD, Graves JE, Smith DI, Heffernan MP Efalizumabinduced subacute cutaneous lupus erythematosus. J Am Acad Dermatol 2006 ; 54: s242 - s243.
46. Miyagawa S., Okuchi T., Shiomi Y., Sakamoto K. Subacute cutaneous lupus erythematosus lesions precipitated by griseofulvin. J Am Acad Dermatol 1989 ; 21: 343-346.
47. Miyagawa S., Sakamoto K. Adverse reactions to griseofulvin in patients with circulating anti-SS-A/Ro and SS-B/La autoantibodies. Am J Med 1989 ; 87: 100-102.
48. Dowdy M., Nigra T., Barth W. Subacute cutaneous lupus erythematosus during PUVA therapy for psoriasis: case report and review of the literature. Arthritis Rheum 1989 ; 32: 343-346.
49. Neumann C. Induktion eines subakuten kutanen lupus erythematodes durch psorale UV-A-therapie. Z. Hautkr 1987 ; 62: 1523-1524, 1527-1528.
50. Brenner W., Gschnait F. Cinnarizin-ein bisher unbekannter induktor eines lupus-erythematodes-ahnlichen syndroms. Der Hautarzt 1978 ; 29: 392-394.
51. Toll A., Campo-Pisa P., Gonzalez-Castro J., et al. Subacute cutaneous lupus erythematosus associated with cinnarizine and thiethylperazine therapy. Lupus 1998 ; 7: 364-366.
52. Nol B. Lupus erythematosus and other autoimmune diseases related to statin therapy: a systematic review. J Eur Acad Dermatol Venereol 2007 ; 21: 17-24.
53. Kerr O., Murray C., Tidman M. Subacute cutaneous lupus erythematosus associated with leflunomide. Clin Exp Dermatol 2004 ; 29: 319-320.
54. Goeb V., Berthelot J., Joly P., et al. Leflunomide-induced subacute cutaneous lupus erythematosus. Rheumatology (Oxford) 2005 ; 44: 823-824.
55. Jian X., Guo G., Ruan Y., Lin D., Li X. Severe cutaneous adverse drug reaction to leflunomide: a report of two cases. Cutan Ocul Toxicol 2008 ; 27: 5-9.
56. Gensburger D., Kawashima M., Marotte H., Kanitakis J., Miossec P. Lupus erythematosus with leflunomide: induction or reactivation?
57. Marazano AV, Ramoni S., Del Papa N., Barbareschi M., Alessi E. Leflunomide-induced subacute cutaneous lupus erythematosus with erythema multiforme-like lesions. Lupus 2008 ; 17: 329-331.
58. Chen M., Crowson A., Woofter M., Luca M., Magro C. Docetaxel (taxotere) induced subacute cutaneous lupus erythematosus: report of 4 cases. J Rheumatol 2004 ; 31: 818-820.
59. Adachi A., Horikawa T. Paclitaxel-indcued cutaneous lupus erythematosus in patients with serum anti-SSA/Ro antibody. J Dermatol 2007 ; 34: 473-476.
60. Ross S., Ormerod A., Roberts C., Dwyer C., Herriot R. Subacute cutaneous lupus erythematosus associated wit phenytoin. Clin Exp Dermatol 2002 ; 27: 474-476.
61. Ghate J., Turner M., Rudek M., et al. Drug-induced lupus associated with col-3: report of 3 cases. Arch Dermatol 2001 ; 137: 471-474.
62. Balsa A., Bernad M., de Miguel E., Crespo. Lupus eritematoso cutaneo subagudo inducido por la crisoterapia en una arthritis reumatoide. Revista Clinica Espanola 1988 ; 182: 505-506.
63. Parodi A., Rivara G., Guarrera M. Possible naproxen-induced relapse of subacute cutaneous lupus erythematosus. JAMA 1992 ; 268: 51-52.
64. Roura M., Lopez-Gil F., Umbert P. Systemic lupus erythematosus exacerbated by piroxicam. Dermatologica 1991 ; 182: 56-58.
65. Sharpiro M., Sosis A., Junkins-Hopkins J., Werth V. Lupus erythematosus induced by medications, ultraviolet radiation, and other exogenous agents: a review, with special focus on the development of subacute cutaneous lupus erythematosus in a genetically predisposed individual. Int J Dermatol 2004 ; 43: 87-94.
66. Crowson A., Magro C. Lichenoid and Subacute cutaneous lupus erythematosus-like dermatitis associated with antihistamine therapy. J Cutan Pathol 1999 ; 26: 95-99.
67. Cassis TB, Callen JP Buproprion-induced subacute cutaneous lupus erythematosus. Australas J Dermatol 2005 ; 46: 266-269.
68. Dam C., Bygum A. Subacute cutaneous lupus erythematosus induced or exacerbated by proton pump inhibitors. Acta Derm Venereol 2008 ; 88: 87-89.
69. Bracke A., Nijsten T., Vandermaesen J., Meuleman L., Lambert J. Lansoprazole-induced subacute cutaneous lupus erythematosus: two cases. Acta Derm Venereol 2005 ; 85: 353-354.
70. Popovic K., Wahren-Herlenius M., Nyberg F. Clinical follow-up of 102 Anti-Ro/SS-A-positive patients with dermatologic manifestations. Acta Derm Venereol 2008 ; 88: 370-375.
71. Capponi A., De Simone C., Guerriero C., Rotoli M., Bartoloni C. Ro/SSA-positive cutaneous lupus erythematosus induced by carbamazepine. Arch Dermatol 2005 ; 141: 103-104.
72. Amerio P., Innocente C., Feliciani C., Angelucci D., Gambi D., Tulli A. Drug-induced cutaneous lupus erythematosus after 5 years of treatment with carbamazepine. Eur J Dermatol 2006 ; 16: 281-283.
73. Fumal I., Danchin A., Cosserat F., Barbaud A., Schmutz JL Subacute cutaneous lupus erythematosus associated with tamoxifen therapy: two cases. Dermatology 2006 ; 210: 251-252.
74. Adachi A., Nagai H., Horikawa T. Anit-SSA/Ro antibody as a risk factor for fluorouracil-induced drug eruptions showing acral erythema and discoid-lupus-erythematosus-like lesions. Dermatology 2007 ; 214: 85-88.
75. Weger W., KrCurrency signnke B., Gerger A., Salmhofer W., Aberer E. Occurrence of subacute cutaneous lupus erythematosus after treatment with fluorouracil and capecitabine. J Am Acad Dermatol 2008 ; 59: s4 - s6.
76. Wiechert A., Tüting T., Bieber T., Haidl G., Wenzel J. Subacute cutaneous lupus erythematosus in a leuprorelin-treated patient with prostate carcinoma. Br J Dermatol 2008 ; 159: 231-232.
77. Reich A., Bialynicki-Birula R., Szepietowski JC Drug-induced subacute cutaneous lupus erythematosus resulting from ticlopidine. Int J Dermatol 2006 ; 45: 1112-1114.
78. Pham H-C., Saurat J-H. Inhalation route inducing subacute cutaneous lupus erythematosus with tiotropium. Arch Dermatol 2005 ; 141: 911-912.
79. Funke AA, Kulp-Shorten CL, Callen JP Subacute cutaneous lupus erythematosus exacerbated by or induced by doxorubicin hydrochloride. Archives of Dermatology 2009.
80. Guhl G., Diaz-Ley B., Garcia-Garcia C., Fraga J., Garcia-Diez A. Chemotherapy-induced subacute lupus erythematosus. Lupus 2009 ; 18: 859-860.